Infliximab improves bone metabolism and bone mineral density in rheumatoid arthritis and ankylosing spondylitis: a prospective 2-year study - Research portal of Justus Liebig University Giessen:

Journal article

Infliximab improves bone metabolism and bone mineral density in rheumatoid arthritis and ankylosing spondylitis: a prospective 2-year study

Authors list: Dischereit, Gabriel; Tarner, Ingo H.; Mueller-Ladner, Ulf; Lange, Uwe

Publication year: 2013

Pages: 377-381

Journal: Clinical Rheumatology

Volume number: 32

Issue number: 3

ISSN: 0770-3198

eISSN: 1434-9949

DOI Link: https://doi.org/10.1007/s10067-012-2128-8

Publisher: Springer

Citation Styles

Harvard Citation style: Dischereit, G., Tarner, I., Mueller-Ladner, U. and Lange, U. (2013) Infliximab improves bone metabolism and bone mineral density in rheumatoid arthritis and ankylosing spondylitis: a prospective 2-year study, Clinical Rheumatology, 32(3), pp. 377-381. https://doi.org/10.1007/s10067-012-2128-8

APA Citation style: Dischereit, G., Tarner, I., Mueller-Ladner, U., & Lange, U. (2013). Infliximab improves bone metabolism and bone mineral density in rheumatoid arthritis and ankylosing spondylitis: a prospective 2-year study. Clinical Rheumatology. 32(3), 377-381. https://doi.org/10.1007/s10067-012-2128-8

Keywords

INCREASE; SERUM-LEVELS; TNF

SDG Areas